FDA Recalls Nitrofurantoin Capsules Due to Failed Dissolution Specifications
Sun Pharmaceutical recalls Nitrofurantoin Capsules (100 mg) due to failed dissolution, affecting medication effectiveness. The recall involves 5,752 bottles nationwide in lots 231067 and 231069.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This is a High severity recall because it involves a Class II manufacturing defect affecting drug efficacy. Per the severity rubric, theoretical product hazards without reported illnesses are limited to High severity, which applies here.
Plain-English summary
Sun Pharmaceutical Industries Inc is recalling Nitrofurantoin Capsules, USP (Macrocrystals), 100 mg, due to failed dissolution specifications. The recall affects 5,752 bottles distributed nationwide in the United States and Puerto Rico.
The capsules failed to meet dissolution specifications, which means they may not dissolve properly in the body. This could reduce the medication's effectiveness in treating urinary tract infections.
The affected products are lot numbers 231067 and 231069, with expiration date of 04/30/2025. The product contains NDC 57664-233-88 and was manufactured by Sidmak Laboratories in Dehradun, India, and distributed from Sun Pharmaceutical's facility in Cranbury, New Jersey.
Consumers who have purchased this medication should stop taking it and consult their healthcare provider. Patients should speak with their pharmacist or doctor about alternative treatments.
The recalled product
- Product
- NITROFURANTION (NITROFURANTION)
- Brand
- NITROFURANTION
- Manufacturer
- SUN PHARMACEUTICAL INDUSTRIES INC
- Category
- Drug — Antibiotic / Oral Capsule
- Hazard
- Affected units
- 5,752
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (3)
- Lot #s: 231067
- 231069
- Exp 04/30/2025
UPCs (3)
- 0357664232187
- 0357664233184
- 0357664231180
Distribution
Related recalls
Same manufacturer · SUN PHARMACEUTICAL INDUSTRIES INC
See all →- HighSun Pharmaceutical Recalls Carbamazepine Tablets Due to Manufacturing Deviations
FDA (Drugs) · 2026-08-26
- LowFexofenadine Hydrochloride Tablets 180 mg Recalled for Impurities
FDA (Drugs) · 2026-07-08
- HighPerampanel Prescription Tablets Recalled for Labeling Mix-up
FDA (Drugs) · 2026-07-01
- HighBudesonide inhalation ampules contain black and brown specks and particles
FDA (Drugs) · 2026-06-17
- SevereDoxorubicin liposome injection vials contain glass particulate matter
FDA (Drugs) · 2026-06-17
Same hazard · dissolution failure
See all →- ModerateMylan Recalls Mycophenolate Mofetil Injection Due to Dissolution Failures
FDA (Drugs) · 2026-09-09
- ModerateApotex Recalls Paxil Tablets for Failed Dissolution and Stability Testing
FDA (Drugs) · 2026-09-02
- ModerateMylan Recalls Acamprosate Calcium Tablets Due to Dissolution Failure
FDA (Drugs) · 2026-08-26
- ModerateChlorthalidone 25mg tablets failed dissolution specifications in two batches
FDA (Drugs) · 2026-06-24
- ModerateNiacin extended-release tablets failed dissolution testing at 24 hours
FDA (Drugs) · 2026-06-17